Follow the people · Insider
Alfred J. Ford Jr.
Alfred J. Ford Jr. files insider transactions with the SEC as a chief commercial officer of Kestra Medical Technologies (KMTS). We hold 4 disclosed purchases and sales filed since 30 April 2007, 4 of them in the last 90 days.
- Files forKMTS
- Disclosed buys and sells4 in all, 4 in the last 90 days
- Last disclosure6 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 7 March 2025 — 4 August 2026Chief Commercial Officer · Kestra Medical Technologies (KMTS)8 Form 4 lines · source: SEC Form 4
- Filed 30 January 2019 — 15 November 2024Chief Commercial Officer · Axonics (AXNX)72 Form 4 lines · source: SEC Form 4
- Filed 1 December 2006 — 1 December 2006VP, Public Access · Cardiac Science (CSCX)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
83 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 6,275 shares of Kestra Medical TechnologiesSEC Form 46 August 2026Common Shares · traded 4 August 2026 · filed 6 August 2026
- ▼ sold on the open market 5,936 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 8,681 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 31 July 2026 · filed 3 August 2026
- ▼ sold on the open market 13,015 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 3 August 2026 · filed 3 August 2026
- was granted 58,832 shares of Kestra Medical TechnologiesSEC Form 417 July 2026Common Shares · traded 15 July 2026 · filed 17 July 2026
- was granted 25,227 shares of Kestra Medical TechnologiesSEC Form 44 June 2026Common Shares · traded 3 June 2026 · filed 4 June 2026
- ▲ bought on the open market 20,000 shares of Kestra Medical TechnologiesSEC Form 415 September 2025Common Shares · traded 7 March 2025 · filed 15 September 2025
- was granted 29,412 shares of Kestra Medical TechnologiesSEC Form 421 July 2025Common Shares · traded 17 July 2025 · filed 21 July 2025
- returned to the issuer 11,250 shares of Axonics (a derivative holding)SEC Form 415 November 2024Performance-Based Restricted Stock Units · traded 15 November 2024 · filed 15 November 2024
- returned to the issuer 4,655 shares of Axonics (a derivative holding)SEC Form 415 November 2024Stock Option (Right to Buy) · traded 15 November 2024 · filed 15 November 2024
- returned to the issuer 43,450 shares of AxonicsSEC Form 415 November 2024Common Stock · traded 15 November 2024 · filed 15 November 2024
- exercised options over 10,500 shares of Axonics (a derivative holding)SEC Form 42 February 2024Performance-Based Restricted Stock Units · traded 31 January 2024 · filed 2 February 2024
- exercised options over 15,000 shares of Axonics (a derivative holding)SEC Form 42 February 2024Performance-Based Restricted Stock Units · traded 31 January 2024 · filed 2 February 2024
- exercised options over 25,500 shares of AxonicsSEC Form 42 February 2024Common Stock · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 16,615 shares of AxonicsSEC Form 42 February 2024Common Stock · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 14,769 shares of AxonicsSEC Form 417 August 2023Common Stock · traded 15 August 2023 · filed 17 August 2023
- ▼ sold on the open market 1,500 shares of AxonicsSEC Form 41 August 2023Common Stock · traded 28 July 2023 · filed 1 August 2023
- was granted 15,000 shares of Axonics (a derivative holding)SEC Form 42 February 2023Performance-Based Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- was granted 7,500 shares of Axonics (a derivative holding)SEC Form 42 February 2023Performance-Based Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- exercised options over 5,250 shares of Axonics (a derivative holding)SEC Form 42 February 2023Performance-Based Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- exercised options over 11,250 shares of Axonics (a derivative holding)SEC Form 42 February 2023Performance-Based Restricted Stock Units · traded 31 January 2023 · filed 2 February 2023
- was granted 7,500 shares of AxonicsSEC Form 42 February 2023Common Stock · traded 31 January 2023 · filed 2 February 2023
- exercised options over 16,500 shares of AxonicsSEC Form 42 February 2023Common Stock · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 4,235 shares of AxonicsSEC Form 42 February 2023Common Stock · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 1,999 shares of AxonicsSEC Form 42 February 2023Common Stock · traded 31 January 2023 · filed 2 February 2023
- ▼ sold on the open market 541 shares of AxonicsSEC Form 42 February 2023Common Stock · traded 1 February 2023 · filed 2 February 2023
- ▼ sold on the open market 3,164 shares of AxonicsSEC Form 42 February 2023Common Stock · traded 1 February 2023 · filed 2 February 2023
- exercised options over 9,310 shares of Axonics (a derivative holding)SEC Form 418 January 2023Stock Option (Right to Buy) · traded 13 January 2023 · filed 18 January 2023
- exercised options over 16,297 shares of Axonics (a derivative holding)SEC Form 418 January 2023Stock Option (Right to Buy) · traded 13 January 2023 · filed 18 January 2023
- exercised options over 1,899 shares of Axonics (a derivative holding)SEC Form 418 January 2023Stock Option (Right to Buy) · traded 13 January 2023 · filed 18 January 2023
- exercised options over 8,509 shares of Axonics (a derivative holding)SEC Form 418 January 2023Stock Option (Right to Buy) · traded 13 January 2023 · filed 18 January 2023
- exercised options over 8,509 shares of AxonicsSEC Form 418 January 2023Common Stock · traded 13 January 2023 · filed 18 January 2023
- exercised options over 1,899 shares of AxonicsSEC Form 418 January 2023Common Stock · traded 13 January 2023 · filed 18 January 2023
- exercised options over 9,310 shares of AxonicsSEC Form 418 January 2023Common Stock · traded 13 January 2023 · filed 18 January 2023
- exercised options over 16,297 shares of AxonicsSEC Form 418 January 2023Common Stock · traded 13 January 2023 · filed 18 January 2023
- ▼ sold on the open market 15,292 shares of AxonicsSEC Form 418 January 2023Common Stock · traded 13 January 2023 · filed 18 January 2023
- ▼ sold on the open market 17,108 shares of AxonicsSEC Form 418 January 2023Common Stock · traded 13 January 2023 · filed 18 January 2023
- ▼ sold on the open market 3,615 shares of AxonicsSEC Form 418 January 2023Common Stock · traded 13 January 2023 · filed 18 January 2023
- was granted 5,250 shares of Axonics (a derivative holding)SEC Form 43 February 2022Performance-Based Restricted Stock Units · traded 31 January 2022 · filed 3 February 2022
- was granted 5,250 shares of Axonics (a derivative holding)SEC Form 43 February 2022Performance-Based Restricted Stock Units · traded 31 January 2022 · filed 3 February 2022
- exercised options over 10,000 shares of Axonics (a derivative holding)SEC Form 43 February 2022Performance-Based Restricted Stock Units · traded 3 February 2022 · filed 3 February 2022
- exercised options over 14,130 shares of Axonics (a derivative holding)SEC Form 43 February 2022Performance-Based Restricted Stock Units · traded 3 February 2022 · filed 3 February 2022
- was granted 16,285 shares of AxonicsSEC Form 43 February 2022Common Stock · traded 31 January 2022 · filed 3 February 2022
- exercised options over 24,130 shares of AxonicsSEC Form 43 February 2022Common Stock · traded 3 February 2022 · filed 3 February 2022
- ▼ sold on the open market 8,797 shares of AxonicsSEC Form 43 February 2022Common Stock · traded 3 February 2022 · filed 3 February 2022
- ▼ sold on the open market 470 shares of AxonicsSEC Form 43 February 2022Common Stock · traded 3 February 2022 · filed 3 February 2022
- exercised options over 6,347 shares of Axonics (a derivative holding)SEC Form 421 April 2021Stock Option (Right to Buy) · traded 19 April 2021 · filed 21 April 2021
- exercised options over 19,258 shares of Axonics (a derivative holding)SEC Form 421 April 2021Stock Option (Right to Buy) · traded 19 April 2021 · filed 21 April 2021
- exercised options over 5,721 shares of Axonics (a derivative holding)SEC Form 421 April 2021Stock Option (Right to Buy) · traded 19 April 2021 · filed 21 April 2021
- exercised options over 14,871 shares of Axonics (a derivative holding)SEC Form 421 April 2021Stock Option (Right to Buy) · traded 19 April 2021 · filed 21 April 2021
- exercised options over 14,871 shares of AxonicsSEC Form 421 April 2021Common Stock · traded 19 April 2021 · filed 21 April 2021
- exercised options over 5,721 shares of AxonicsSEC Form 421 April 2021Common Stock · traded 19 April 2021 · filed 21 April 2021
- exercised options over 19,258 shares of AxonicsSEC Form 421 April 2021Common Stock · traded 19 April 2021 · filed 21 April 2021
- exercised options over 6,347 shares of AxonicsSEC Form 421 April 2021Common Stock · traded 19 April 2021 · filed 21 April 2021
- ▼ sold on the open market 41,794 shares of AxonicsSEC Form 421 April 2021Common Stock · traded 19 April 2021 · filed 21 April 2021
- ▼ sold on the open market 12,502 shares of AxonicsSEC Form 421 April 2021Common Stock · traded 19 April 2021 · filed 21 April 2021
- was granted 10,000 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 42 February 2021Performance-Based Restricted Stock Units · traded 31 January 2021 · filed 2 February 2021
- was granted 5,625 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 42 February 2021Performance-Based Restricted Stock Units · traded 31 January 2021 · filed 2 February 2021
- exercised options over 2,667 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 42 February 2021Performance-Based Restricted Stock Units · traded 1 February 2021 · filed 2 February 2021
- was granted 5,625 shares of Axonics Modulation TechnologiesSEC Form 42 February 2021Common Stock · traded 31 January 2021 · filed 2 February 2021
- exercised options over 5,334 shares of Axonics Modulation TechnologiesSEC Form 42 February 2021Common Stock · traded 1 February 2021 · filed 2 February 2021
- ▼ sold on the open market 1,751 shares of Axonics Modulation TechnologiesSEC Form 42 February 2021Common Stock · traded 1 February 2021 · filed 2 February 2021
- ▼ sold on the open market 132 shares of Axonics Modulation TechnologiesSEC Form 42 February 2021Common Stock · traded 1 February 2021 · filed 2 February 2021
- exercised options over 7,065 shares of Axonics Modulation TechnologiesSEC Form 427 January 2021Common Stock · traded 26 January 2021 · filed 27 January 2021
- ▼ sold on the open market 2,417 shares of Axonics Modulation TechnologiesSEC Form 427 January 2021Common Stock · traded 26 January 2021 · filed 27 January 2021
- exercised options over 7,065 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 427 January 2021Performance-Based Restricted Stock Units · traded 26 January 2021 · filed 27 January 2021
- exercised options over 35,000 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 42 September 2020Stock Option (Right to Buy) · traded 2 September 2020 · filed 2 September 2020
- ▼ sold on the open market 2,667 shares of Axonics Modulation TechnologiesSEC Form 42 September 2020Common Stock · traded 31 August 2020 · filed 2 September 2020
- exercised options over 35,000 shares of Axonics Modulation TechnologiesSEC Form 42 September 2020Common Stock · traded 2 September 2020 · filed 2 September 2020
- ▼ sold on the open market 11,031 shares of Axonics Modulation TechnologiesSEC Form 42 September 2020Common Stock · traded 2 September 2020 · filed 2 September 2020
- ▼ sold on the open market 23,743 shares of Axonics Modulation TechnologiesSEC Form 42 September 2020Common Stock · traded 2 September 2020 · filed 2 September 2020
- ▼ sold on the open market 226 shares of Axonics Modulation TechnologiesSEC Form 42 September 2020Common Stock · traded 2 September 2020 · filed 2 September 2020
- exercised options over 2,667 shares of Axonics Modulation TechnologiesSEC Form 43 February 2020Common Stock · traded 30 January 2020 · filed 3 February 2020
- exercised options over 2,667 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 43 February 2020Performance-Based Restricted Stock Units · traded 30 January 2020 · filed 3 February 2020
- was granted 7,065 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 416 December 2019Performance-Based Restricted Stock Units · traded 12 December 2019 · filed 16 December 2019
- was granted 7,065 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 416 December 2019Performance-Based Restricted Stock Units · traded 12 December 2019 · filed 16 December 2019
- was granted 20,312 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 416 December 2019Stock Option (Right to Buy) · traded 12 December 2019 · filed 16 December 2019
- was granted 35,555 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 41 February 2019Stock Option (Right to Buy) · traded 30 January 2019 · filed 1 February 2019
- was granted 2,667 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 41 February 2019Performance-Based Restricted Stock Units · traded 30 January 2019 · filed 1 February 2019
- was granted 2,667 shares of Axonics Modulation Technologies (a derivative holding)SEC Form 41 February 2019Performance-Based Restricted Stock Units · traded 30 January 2019 · filed 1 February 2019
- exercised options over 175 shares of Cardiac Science (a derivative holding)SEC Form 430 April 2007Restricted Stock Units · traded 1 December 2006 · filed 30 April 2007
- exercised options over 175 shares of Cardiac ScienceSEC Form 430 April 2007Common Stock · traded 1 December 2006 · filed 30 April 2007
- had shares withheld for tax on 60 shares of Cardiac ScienceSEC Form 430 April 2007Common Stock · traded 1 December 2006 · filed 30 April 2007
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.